NDRG2 has previously been shown to be negatively regulated by the c-Myc oncoprotein [8] and it is possible that elevated levels of c-Myc would result in reduced expression of NDRG2. Thus, it could be interesting to elucidate whether or not an increased level of c-Myc, which is a frequent event in colorectal cancer [18], correlates with a decreased level of NDRG2. Measurement of c-Myc levels was not included in these studies. The gene discussed is NDRG2; the disease is colorectal cancer.